Member Info for Toukankahmoon

Don’t expect an answer from CJ62. Because your concerns could be well founded.

But it’s not worth stressing about because in a couple of months we should have the data to enlighten us all one way or another.

Doggy

If we hit 255p today I think a lot of us would sell quite a few shares😁

Wyndrum

As usual the knowledgeable seasoned investors resort to the usual playground tactics. So immature and yet they then expect to be taken seriously.

AIM was set up to make it easier for startups to raise early seed money. If it wasn’t for AIM there wouldn’t be an Avacta. The idea that AIM is holding the SP down will be blown out the water when hopefully they can conjure up some convincing results.

Pedrol

“he insults us all”? Oh the irony 🤣

13th

You make it sound simples. But it obviously isn’t because if it was the SP would 🚀

But as I have said over and over, I too expect it to succeed. I just caution anyone not to “bet the farm”. It is not a slam dunk yet.

IceCool Pedro

“AIM is clueless “. Along with all the others I mention. Your arrogance (and naivety) is staggering. I would love to meet these people who know more than all the knowledgeable experts. But at the end of the day it doesn’t matter what Ice, PL75, cJ62 or any of us think. Until the people who matter are convinced then the SP will continue roughly sideways.

IceCool

I really hope you are right

Just in case there are any rational grown ups on this BB, who do you believe more ? CC, big pharma, institutional investors and any others that influence the SP or the self appointed censorship team on here who cannot bear to see views contrary to their own because they are so insecure. They tell us that everyone but them is blind to the value of Avacta and yet in the next breadth that deals are being done under FDAs because big pharma are privy to much more data than we see.

So super intelligent well seasoned investors why is the SP at 77p.

IceCool

Where does it say it’s new data.

They went to the trouble of presenting a 6000 poster at AACR but none of it was new and the data cutoff date was last September and yet you don’t think that this of concern.

Couldn’t agree more. But perhaps we need a more uplifting post from IceCool to explain it to us.

IceCool

. . . and what do you think the data cutoff date will be for the 6000 paper at ASCO in May?

PL75

Desperate or what?

Just wait patiently for the real results. All this hysteria for the slightest reason isn’t going to your health any good. Calm down

IceCool

Doesn’t it make you wonder why the AVA6000 data cutoff is still September? That’s 7 months ago. They must have more up to date results. Why aren’t they sharing them?

PL 75

What was new apart from AI simulation based on pre clinical data?

Saint

Thanks.

Rampers notably quiet. Guess it wasn’t what you were expecting

If only you could just wait patiently.

The US facility isn’t a listing as such. It’s basically a shop window. It will always track the SP give or take exchange rates.

We’ve already had this argument/discussion over on AVCT!!!

Aldebaran

Yes. Would be nice. At least now we seem to have a PR function that understands the value of frequent positive news flow.

13thMmonkey

“It’s a community of investors sharing research”

Except if someone dares to question the fanspeak or point out fake news.

IceCool

Some rationality when people who can’t read start threads saying “6103 works in humans” when clearly that isn’t quite what the RNS says

As I said:

It is a very positive RNS. But don’t pretend that it’s talking about the first 6103 dosee. It isn’t as far as I can see from reading ALL the words.

So the title of this thread is totally misleading. 6103 works in an AI model of humans should be the accurate title.